Comparing Bacitracin / Polymyxin B Ophthalmic vs Dexamethasone / Neomycin / Polymyxin B Ophthalmic
| Bacitracin / polymyxin b ophthalmic | Dexamethasone / neomycin / polymyxin b ophthalmic |
|
|---|
| Bacitracin / polymyxin b ophthalmic | Dexamethasone / neomycin / polymyxin b ophthalmic |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hordeolum, Blepharitis, Conjunctivitis - Bacterial, Blepharoconjunctivitis, Keratitis, Keratoconjunctivitis. Bacitracin / polymyxin b ophthalmic may also be used for purposes not... View more |
Prescription only
Prescribed for Blepharitis, Conjunctivitis - Bacterial, Uveitis, Keratitis, Keratoconjunctivitis. Dexamethasone / neomycin / polymyxin b ophthalmic may also be used for purposes not listed in this... View more |
Related suggestions Conjunctivitis, Bacterial
Blepharitis
Keratoconjunctivitis
|
|||||||
| More about Bacitracin / polymyxin b ophthalmic | More about Dexamethasone / neomycin / polymyxin b ophthalmic | ||||||||
| Ratings & Reviews | |||||||||
|
Bacitracin / polymyxin b ophthalmic has an average rating of 10.0 out of 10 from a total of 4 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Dexamethasone / neomycin / polymyxin b ophthalmic has an average rating of 7.1 out of 10 from a total of 13 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Dexamethasone / neomycin / polymyxin b ophthalmic side effects |
|||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
Lower cost generic |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Dexamethasone / neomycin / polymyxin b ophthalmic prices |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| AK-Poly-Bac, Polycin | AK-Trol, Dexacine, Dexasporin, Maxitrol, Neo-Poly-Dex, NPD Ophthalmic Ointment, Poly-Dex | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
N/A |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 99 drugs are known to interact with Dexamethasone / neomycin / polymyxin b ophthalmic:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
| First Approval Date | |||||||||
|
April 16, 1974 |
July 19, 1963 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
|||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.